ADCS Prevention Instrument Project: Assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials

Alzheimer Disease and Associated Disorders

Volumn 20, Issue SUPPL. 3, 2006, Pages

  Galasko, Douglas ^a   Bennett, David A ^b   Sano, Mary ^c,d   Marson, Daniel ^e   Kaye, Jeff ^f   Edland, Steven D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Activities of daily living; Alzheimer disease; Clinical trial

Indexed keywords

ACTIVITIES OF DAILY LIVING PREVENTION INSTRUMENT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; COHORT ANALYSIS; COMMUNITY CARE; DAILY LIFE ACTIVITY; DEMENTIA; ELDERLY CARE; EVALUATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT ACTIVITIES OF DAILY LIVING QUESTIONNAIRE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF CONCEPT; SELF EVALUATION;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMBULATORY CARE FACILITIES; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PRIMARY PREVENTION; PROXY; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); UNITED STATES;

EID: 33845431168     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000213873.25053.2b     Document Type: Article

References (9)

1. Ferris SH, Aisen PS, Cummings J, et al. ADCS prevention instrument project: overview and initial results. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S109-S123.
2. Pfeffer RI, Kurosaki TT, Harrah CH Jr, et al. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323-329.
3. Feldman H, Sauter A, Donald A, et al. The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Dis Assoc Disord. 2001;15:89-95.
4. Berg L. Clinical dementia rating (CDR). Psychopharmacology Bull. 1988;24:637-639.
5. Galasko D, Bennett D, Sano M, et al. An Inventory to assess activities of daily living for clinical trials in Alzheimer's Disease. Alzheimer Dis Assoc Disord. 1997;11(suppl 2):S33-S39.
6. Carr DB, Gray S, Baty J, et al. The value of informant versus individual's complaints of memory impairment in early dementia. Neurology. 2000;55:1724-1726.
7. Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758-764.
8. Wadley VG, Harrell LE, Marson DC. Self- and informant report of financial abilities in patients with Alzheimer's disease: reliable and valid? J Am Geriatr Soc. 2003;51:1621-1626.
9. Petersen RC, Thomas RD, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379-2388.